Quetiapine for schizophrenia: more transparency needed in clinical trial reporting

shutterstock_122223547

Andrew Shepherd reports on a recent systematic review, meta-analysis and reappraisal of Quetiapine for schizophrenia, which concludes that Quetiapine IR has a small beneficial effect on psychotic symptoms, but also leads to weight gain and sedation.

[read the full story...]

Are treatments for bipolar disorder cost-effective?

shutterstock_177676103

Chris Sampson reports on a recent systematic review and critical appraisal of economic evaluations in bipolar disorder. He finds that there’s a pressing need for new studies, especially discrete event simulations.

[read the full story...]

Cochrane review finds quetiapine is equivalent in efficacy to typical antipsychotics and possibly causes fewer side effects

Antipsychotic medication is the standard treatment for schizophrenia and psychosis in the UK.  Given that psychosis is commonly a chronic condition and therefore that medication used to treat it often needs to be taken for several years, getting the medication “right” is important. As I mentioned in my first blog post for the Mental Elf, [read the full story…]